May 17, 2021 7:00 am EDT Acasti Intends to Request Hearing Before Nasdaq Panel to Present Plan of Compliance
Nov 16, 2020 6:55 am EST Acasti Pharma Provides Business Update for the Second Quarter of Fiscal 2021
Oct 1, 2020 4:30 pm EDT Acasti Pharma Announces the Election of Its Directors, Advisory Resolution Approving Compensation, Amendments to Its Stock Option and Equity Incentive Plans, Adoption of Amended & Restated General By-Law and Other Related Matters Approved at Its AGM